Wir sind mit live! Mehr erfahren

Surgery Partners

SGRY

Börsenwert 1,91 Mrd. $

14,61 USD

-0,16

1,08 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

14,61

0,00

0 %

1 Tag

-1,08 %

5 Tage

5,49 %

1 Monat

4,88 %

3 Monate

-12,2 %

6 Monate

8,79 %

Seit Jahresbeginn

-4,26 %

1 Jahr

-30,86 %

5 Jahre

-65,16 %

10 Jahre

-27,39 %

Profil: Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Mitarbeiter: 16.000

Gesundheitswesen Medizinische Versorgungseinrichtungen

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 63,6 %

Neutral 36,4 %

Negativ 0 %

Zacks Investment Research

Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment

I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also simplifies its business and boosts its valuation appeal as a short-stay surgical pure-play. I see significant upside from the $60B inpatient-to-outpatient migration, supported by robust practitioner recruitment and disciplined acquisition strategy.

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health.

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

The Motley Fool

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares

The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares

Zacks Investment Research

Likely ETF & Stock Winners From July Jobs Report

Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.

Likely ETF & Stock Winners From July Jobs Report

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Surgery Partners Q2 Earnings Call Highlights

Surgery Partners NASDAQ: SGRY reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its Idaho Falls market operations to Intermountain Health.

Surgery Partners Q2 Earnings Call Highlights

Zacks Investment Research

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Zacks Investment Research

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

Surgery Partners, Inc. (NASDAQ:SGRY) stock is trading higher on Friday as the company announced a significant transaction involving the sale of its ownership interests in Idaho Falls facilities to Intermountain Health.

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt